Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response
Molecules and Cells · 2023
DOI: 10.14348/molcells.2023.0005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules and Cells, 2023. Verfasst von Aryatara Shakya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA. Hauptthemen laut MEDLINE: Antioxidants, NF-E2-Related Factor 2. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0). Gefördert von: NIEHS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The transcription factor Nrf2 was originally identified as a master regulator of redox homeostasis, as it governs the expression of a battery of genes involved in mitigating oxidative and electrophilic stress. However, the central role of Nrf2 in dictating multiple facets of the cellular stress response has defined the Nrf2 pathway as a general mediator of cell survival. Recent studies have indicated that Nrf2 regulates the expression of genes controlling ferroptosis, an ironand lipid peroxidation-dependent form of cell death. While Nrf2 was initially thought to have anti-ferroptotic function primarily through regulation of the antioxidant response, accumulating evidence has indicated that Nrf2 also exerts anti-ferroptotic effects via regulation of key aspects of iron and lipid metabolism. In this review, we will explore the emerging role of Nrf2 in mediating iron homeostasis and lipid peroxidation, where several Nrf2 target genes have been identified that encode critical proteins involved in these pathways. A better understanding of the mechanistic relationship between Nrf2 and ferroptosis, including how genetic and/or pharmacological manipulation of Nrf2 affect the ferroptotic response, should facilitate the development of new therapies that can be used to treat ferroptosis-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
- The University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
ORCID-Profile: Aryatara Shakya, Nicholas W McKee, Matthew Dodson, Eli Chapman, Donna D Zhang
Förderung
- NIEHS NIH HHS
- National Institutes of Health
Zitieren
APA
Shakya, A., McKee, N. W., Dodson, M., Chapman, E., & Zhang, D. D. (2023). Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. Molecules and Cells. https://doi.org/10.14348/molcells.2023.0005
Vancouver
Shakya A, McKee NW, Dodson M, Chapman E, Zhang DD. Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. Molecules and Cells. 2023. doi:10.14348/molcells.2023.0005
BibTeX
@article{Shakya2023,
author = {Shakya, Aryatara and McKee, Nicholas W and Dodson, Matthew and Chapman, Eli and Zhang, Donna D},
title = {Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response},
journal = {Molecules and Cells},
year = {2023},
doi = {10.14348/molcells.2023.0005}
}
EUVIMED